These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 1852791)

  • 21. Pathophysiology of motor complications in Parkinson disease: postsynaptic mechanisms are crucial.
    Linazasoro G
    Arch Neurol; 2007 Jan; 64(1):137-40. PubMed ID: 17210824
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.
    Guigoni C; Aubert I; Li Q; Gurevich VV; Benovic JL; Ferry S; Mach U; Stark H; Leriche L; Håkansson K; Bioulac BH; Gross CE; Sokoloff P; Fisone G; Gurevich EV; Bloch B; Bezard E
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S25-9. PubMed ID: 15885624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of motor complications in treatment of Parkinson's disease.
    Kumar A; Huang Z; de la Fuente-Fernández R
    Adv Neurol; 2003; 91():193-201. PubMed ID: 12442678
    [No Abstract]   [Full Text] [Related]  

  • 24. Functional consequences of dopaminergic degeneration in Parkinson's disease.
    Tedroff JM
    Adv Neurol; 1999; 80():67-70. PubMed ID: 10410704
    [No Abstract]   [Full Text] [Related]  

  • 25. Strategies to modify levodopa treatment.
    Widner H
    Adv Neurol; 2003; 91():229-36. PubMed ID: 12442681
    [No Abstract]   [Full Text] [Related]  

  • 26. [Tardive dyskinesia. After more than 2 decades].
    Lajeunesse C; Villeneuve A
    Encephale; 1989; 15(5):471-85. PubMed ID: 2574103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management of patients with early Parkinson's disease.
    Rascol O; Brefel-Courbon C; Payoux P; Ferreira J
    Adv Neurol; 2003; 91():203-11. PubMed ID: 12442679
    [No Abstract]   [Full Text] [Related]  

  • 28. Dysphagia in movement disorders.
    Logemann JA
    Adv Neurol; 1988; 49():307-16. PubMed ID: 2964174
    [No Abstract]   [Full Text] [Related]  

  • 29. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA; Gautier J
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of occurrence, severity, and course of tardive dyskinesia in an outpatient population.
    Glazer WM; Morgenstern H
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):10S-16S. PubMed ID: 3065363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
    Pham DQ; Plakogiannis R
    Ann Pharmacother; 2005 Dec; 39(12):2065-72. PubMed ID: 16288072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of advanced Parkinson's disease: an evidence-based analysis.
    Goetz CG
    Adv Neurol; 2003; 91():213-28. PubMed ID: 12442680
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical pharmacology of levodopa-induced dyskinesia.
    Nutt JG
    Ann Neurol; 2000 Apr; 47(4 Suppl 1):S160-4; discussion S164-6. PubMed ID: 10762144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New aspects in the pathophysiology of dyskinesia. Salpêtrière Deep Brain Stimulation Group.
    Damier P
    Adv Neurol; 1999; 80():611-7. PubMed ID: 10410778
    [No Abstract]   [Full Text] [Related]  

  • 35. Current views on tardive dyskinesia.
    Gerlach J
    Pharmacopsychiatry; 1991 Mar; 24(2):47-8. PubMed ID: 1852791
    [No Abstract]   [Full Text] [Related]  

  • 36. The endocrinology of extrapyramidal system disorders.
    Kirkpatrick B; Tamminga CA
    Endocrinol Metab Clin North Am; 1988 Mar; 17(1):159-72. PubMed ID: 2967753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies.
    Bezard E; Brotchie JM; Gross CE
    Nat Rev Neurosci; 2001 Aug; 2(8):577-88. PubMed ID: 11484001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.